272 related articles for article (PubMed ID: 11689630)
1. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
[TBL] [Abstract][Full Text] [Related]
2. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
3. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
4. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection.
Vingert BC; Le Grand R; Venet A
Microbes Infect; 2003 Jul; 5(9):757-67. PubMed ID: 12850201
[TBL] [Abstract][Full Text] [Related]
6. Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques.
Stevceva L; Moniuszko M; Alvarez X; Lackner AA; Franchini G
Virology; 2004 Feb; 319(2):190-200. PubMed ID: 14980480
[TBL] [Abstract][Full Text] [Related]
7. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
[TBL] [Abstract][Full Text] [Related]
8. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
Kuroda MJ; Schmitz JE; Barouch DH; Craiu A; Allen TM; Sette A; Watkins DI; Forman MA; Letvin NL
J Exp Med; 1998 May; 187(9):1373-81. PubMed ID: 9565630
[TBL] [Abstract][Full Text] [Related]
10. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; Napoé G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
[TBL] [Abstract][Full Text] [Related]
11. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
[TBL] [Abstract][Full Text] [Related]
12. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
Metzner KJ; Moretto WJ; Donahoe SM; Jin X; Gettie A; Montefiori DC; Marx PA; Binley JM; Nixon DF; Connor RI
J Gen Virol; 2005 Dec; 86(Pt 12):3375-3384. PubMed ID: 16298985
[TBL] [Abstract][Full Text] [Related]
14. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP
J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977
[TBL] [Abstract][Full Text] [Related]
15. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
[TBL] [Abstract][Full Text] [Related]
16. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
17. Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.
Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Mansfield KG; Carville A; Aldovini A
J Immunol; 2011 Mar; 186(6):3581-93. PubMed ID: 21317390
[TBL] [Abstract][Full Text] [Related]
18. Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.
Veazey RS; Acierno PM; McEvers KJ; Baumeister SH; Foster GJ; Rett MD; Newberg MH; Kuroda MJ; Williams K; Kim EY; Wolinsky SM; Rieber EP; Piatak M; Lifson JD; Montefiori DC; Brown CR; Hirsch VM; Schmitz JE
J Virol; 2008 Jun; 82(11):5618-30. PubMed ID: 18367534
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
J Virol; 1998 May; 72(5):4170-82. PubMed ID: 9557706
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL
J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
